Novus Biologicals™ Recombinant Human VEGF 165 Protein

Description

Recombinant Protein

Fully biologically active when compared to standard. The ED50 as determined by a cell proliferation assay using human umbilical vein endothelial cells(HUVEC) is between 1.0-8.0 ng/mL.

Specifications

• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered concentrated solution in PBS (pH 7.4), 0.02% Tween-20.
• Gene ID (Entrez): 7422
• Quantity: 100 μg
• Storage Requirements: Store at -20°C to -70°C as supplied. After reconstitution, store at 2 to 8 C for 1 month and (at -20°C to -70°C for long term storage. Avoid repeated freeze/thaw cycles.)
• Endotoxin Concentration: Less than 0.1 EU/μg of VEGF 165 AS determined by LAL method.
• Gene Alias: biosimilar, biosimilars, MVCD1, vascular endothelial growth factor A, Vascular permeability factor, VEGF-A, VEGFMGC70609, VPFvascular endothelial growth factor
• Gene Symbol: VEGFA
• Conjugate: Unconjugated
• Species: Human
• Recombinant: Recombinant
• Reconstitution: Briefly centrifuge prior to opening vial to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1% BSA to 0.1-1.0 mg/mL Stock solutions should be apportioned into working aliquots and stored (at -20°C.)
• Form: Purified
• Research Category: Angiogenesis, Biologically Active Proteins
• Purity or Quality Grade: >97 % pure by SDS-PAGE and HPLC
• Protein: VEGF 165